Technology

Brainsway

$7.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-1.69%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Brainsway and other stocks, options, and ETFs commission-free!

About BWAY

Brainsway Ltd. American Depositary Shares, also called Brainsway, is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel. The listed name for BWAY is Brainsway Ltd. American Depositary Shares.

CEO
Christopher von Jako
Employees
107
Headquarters
Jerusalem, Jerusalem
Founded
2006
Market Cap
89.00M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
33.74K
High Today
$7.95
Low Today
$7.82
Open Price
$7.82
Volume
13.45K
52 Week High
$12.53
52 Week Low
$5.10

Collections

BWAY Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, Pre-Market

You May Also Like

DMO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure